New approvals — United Kingdom

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

23 Jul 2024Tuesday 23 July 2024

open day ◀ ▶ 1 event

MHRA approval GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems

Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease

What this means, batches, details

Loading…

details and permanent link MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 1 event in this category.

Key

class 1 recall (risk to life)

class 2–3 recall, serious shortage, safety update

class 4 defect notification, new approval

A batch recall does not mean the medicine is withdrawn: it remains licensed, only the listed batches are affected.

Sources

MHRA alerts — medicines recalls and defect notifications since January 2024.
Drug Safety Update.
Serious Shortage Protocols (NHSBSA).